PE20.04 The impact of TGF-β on the genital immune environment associated with HIV risk in young womenE-posterMucosal immunity
PE20.05 Impact of gender affirmation surgery and exogenous hormones on mucosal immune responses and risk of HIV transmission in transgender womenE-posterMucosal immunity
PE20.06 Acute sexual violence exposure dysregulates HIV associated cervical immune biomarkers in womenE-posterMucosal immunity
PE20.07 Effects of continued Progestin-based contraceptive usage in the adolescent genital tract: implications for HIV acquisitionE-posterMucosal immunity
PE20.08 The impact of human immunodeficiency virus-1 viral replicative capacity on infection of human cervical and rectal tissue explants ex vivoE-posterMucosal immunity
PU20.01 Vaccination with Ad26.ZEBOV, MVA-BN-Filo or MVA-BN-Filo, Ad26.ZEBOV induced predominantly IgG binding to Ebola glycoprotein in cervico-vaginal mucus in HIV-infected and uninfected participantsPublication OnlyMucosal immunity
PU20.02 Asymptomatic bacterial STI in young men who have sex with men minimally alters rectal mucosal immune cell ecosystemPublication OnlyMucosal immunity
OA05.03 Compartment specific changes of Innate Lymphoid Cells within the intestinal mucosa of HIV-1 infected individualsOral Abstract SessionMicrobiome & STI: impact on prevention
OA19.01 Impact of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomized placebo-controlled trialOral Abstract SessionMicrobiome & STI: impact on prevention
OA19.02 Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new speciesOral Abstract SessionMicrobiome & STI: impact on prevention
seek-warrow-warrow-eseek-e101 - 110 of 444 items